Does PEMBROLIZUMAB Cause Cholecystitis? 245 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 245 reports of Cholecystitis have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.3% of all adverse event reports for PEMBROLIZUMAB.
245
Reports of Cholecystitis with PEMBROLIZUMAB
0.3%
of all PEMBROLIZUMAB reports
15
Deaths
179
Hospitalizations
How Dangerous Is Cholecystitis From PEMBROLIZUMAB?
Of the 245 reports, 15 (6.1%) resulted in death, 179 (73.1%) required hospitalization, and 10 (4.1%) were considered life-threatening.
Is Cholecystitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 245 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Cholecystitis?
LENVATINIB (309)
SEMAGLUTIDE (293)
ADALIMUMAB (234)
METHOTREXATE (205)
NIVOLUMAB (183)
RITUXIMAB (159)
LENALIDOMIDE (144)
BEVACIZUMAB (131)
CYCLOPHOSPHAMIDE (131)
DEXAMETHASONE (126)
Which PEMBROLIZUMAB Alternatives Have Lower Cholecystitis Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G